High-dose methylprednisolone pulse therapy during refractory COVID-19 acute respiratory distress syndrome: a retrospective observational study

BACKGROUND: Current COVID-19 guidelines recommend the early use of systemic corticoids for COVID-19 acute respiratory distress syndrome (ARDS). It remains unknown if high-dose methylprednisolone pulse therapy (MPT) ameliorates refractory COVID-19 ARDS after many days of mechanical ventilation or rap...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeiner, Carsten, Schröder, Malte, Metzner, Selina, Herrmann, Johannes, Notz, Quirin, Hottenrott, Sebastian, Röder, Daniel, Meybohm, Patrick, Lepper, Philipp M., Lotz, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546709/
https://www.ncbi.nlm.nih.gov/pubmed/37789367
http://dx.doi.org/10.1186/s12890-023-02664-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546709/
https://www.ncbi.nlm.nih.gov/pubmed/37789367
http://dx.doi.org/10.1186/s12890-023-02664-5

Ejemplares similares